Pentoxifylline Add-On Therapy for Mild-to-Moderate Plaque Psoriasis
NCT07626788
·
clinicaltrials.gov ↗
NA
Phase
NOT_YET_RECRUITING
Status
140
Enrollment
OTHER
Sponsor class
Conditions
Psoriasis
Interventions
DRUG:
Pentoxifylline 400 mg Oral Tablet
DRUG:
Placebo
Sponsor
Wasuchon Chaichan